| Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks J Khan, JS Wei, M Ringner, LH Saal, M Ladanyi, F Westermann, ... Nature medicine 7 (6), 673-679, 2001 | 3614 | 2001 |
| The genetic landscape of high-risk neuroblastoma TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ... Nature genetics 45 (3), 279-284, 2013 | 1285 | 2013 |
| Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ... Cancer discovery 4 (2), 216-231, 2014 | 759 | 2014 |
| Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators Y Yu, J Khan, C Khanna, L Helman, PS Meltzer, G Merlino Nature medicine 10 (2), 175-181, 2004 | 743 | 2004 |
| Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome AP Hsu, EP Sampaio, J Khan, KR Calvo, JE Lemieux, SY Patel, ... Blood, The Journal of the American Society of Hematology 118 (10), 2653-2655, 2011 | 707 | 2011 |
| Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays J Khan, R Simon, M Bittner, Y Chen, SB Leighton, T Pohida, PD Smith, ... Cancer Research 58 (22), 5009-5013, 1998 | 631 | 1998 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 596 | 2015 |
| The pediatric preclinical testing program: description of models and early testing results PJ Houghton, CL Morton, C Tucker, D Payne, E Favours, C Cole, ... Pediatric blood & cancer 49 (7), 928-940, 2007 | 519 | 2007 |
| International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee PF Ambros, IM Ambros, GM Brodeur, M Haber, J Khan, A Nakagawara, ... British journal of cancer 100 (9), 1471-1482, 2009 | 473 | 2009 |
| The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation AS Brohl, DA Solomon, W Chang, J Wang, Y Song, S Sindiri, R Patidar, ... PLoS genetics 10 (7), e1004475, 2014 | 454 | 2014 |
| CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity E Jacoby, SM Nguyen, TJ Fountaine, K Welp, B Gryder, H Qin, Y Yang, ... Nature communications 7 (1), 12320, 2016 | 440 | 2016 |
| cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene J Khan, ML Bittner, LH Saal, U Teichmann, DO Azorsa, GC Gooden, ... Proceedings of the National Academy of Sciences 96 (23), 13264-13269, 1999 | 396 | 1999 |
| A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency Q Zhou, GS Lee, J Brady, S Datta, M Katan, A Sheikh, MS Martins, ... The American Journal of Human Genetics 91 (4), 713-720, 2012 | 395 | 2012 |
| Metastasis-associated differences in gene expression in a murine model of osteosarcoma C Khanna, J Khan, P Nguyen, J Prehn, J Caylor, C Yeung, J Trepel, ... Cancer research 61 (9), 3750-3759, 2001 | 381 | 2001 |
| Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models JGT Vi, AT Cheuk, PS Tsang, JY Chung, YK Song, K Desai, Y Yu, ... The Journal of clinical investigation 119 (11), 3395-3407, 2009 | 373 | 2009 |
| The MYCN oncogene is a direct target of miR-34a JS Wei, YK Song, S Durinck, QR Chen, ATC Cheuk, P Tsang, Q Zhang, ... Oncogene 27 (39), 5204-5213, 2008 | 359 | 2008 |
| Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism DA Oldridge, AC Wood, N Weichert-Leahey, I Crimmins, R Sussman, ... Nature 528 (7582), 418-421, 2015 | 329 | 2015 |
| DNA microarray technology: the anticipated impact on the study of human disease J Khan, ML Bittner, Y Chen, PS Meltzer, JM Trent Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1423 (2), M17-M28, 1999 | 294 | 1999 |
| PAX3–FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability BE Gryder, ME Yohe, HC Chou, X Zhang, J Marques, M Wachtel, ... Cancer Discovery 7 (8), 884-899, 2017 | 293 | 2017 |
| Expression profiling in cancer using cDNA microarrays J Khan, LH Saal, ML Bittner, Y Chen, JM Trent, PS Meltzer ELECTROPHORESIS: An International Journal 20 (2), 223-229, 1999 | 289 | 1999 |
Jun S. WeiNational Cancer Institute, National Institutes of HealthE-mail megerősítve itt: mail.nih.gov